JP2017510590A5 - - Google Patents

Download PDF

Info

Publication number
JP2017510590A5
JP2017510590A5 JP2016559366A JP2016559366A JP2017510590A5 JP 2017510590 A5 JP2017510590 A5 JP 2017510590A5 JP 2016559366 A JP2016559366 A JP 2016559366A JP 2016559366 A JP2016559366 A JP 2016559366A JP 2017510590 A5 JP2017510590 A5 JP 2017510590A5
Authority
JP
Japan
Prior art keywords
spiro
methyl
dihydro
triaza
diaza
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016559366A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017510590A (ja
JP6434989B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/000528 external-priority patent/WO2015144290A1/en
Publication of JP2017510590A publication Critical patent/JP2017510590A/ja
Publication of JP2017510590A5 publication Critical patent/JP2017510590A5/ja
Application granted granted Critical
Publication of JP6434989B2 publication Critical patent/JP6434989B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016559366A 2014-03-27 2015-03-10 ピリジルピペリジン Expired - Fee Related JP6434989B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14001145 2014-03-27
EP14001145.3 2014-03-27
PCT/EP2015/000528 WO2015144290A1 (en) 2014-03-27 2015-03-10 Pyridyl piperidines

Publications (3)

Publication Number Publication Date
JP2017510590A JP2017510590A (ja) 2017-04-13
JP2017510590A5 true JP2017510590A5 (https=) 2018-04-19
JP6434989B2 JP6434989B2 (ja) 2018-12-05

Family

ID=50389770

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016559366A Expired - Fee Related JP6434989B2 (ja) 2014-03-27 2015-03-10 ピリジルピペリジン

Country Status (9)

Country Link
US (1) US9926319B2 (https=)
EP (1) EP3122739B1 (https=)
JP (1) JP6434989B2 (https=)
CN (1) CN106458992B (https=)
AU (1) AU2015236855B2 (https=)
CA (1) CA2943659C (https=)
ES (1) ES2720324T3 (https=)
IL (1) IL247728B (https=)
WO (1) WO2015144290A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6447304B2 (ja) * 2015-03-27 2019-01-09 Jsr株式会社 液晶配向剤、液晶配向膜及びその製造方法、液晶表示素子、位相差フィルム及びその製造方法、重合体並びに化合物
EP3303332A1 (en) 2015-06-01 2018-04-11 Bantam Pharmaceutical, LLC Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating thereto
MX390651B (es) * 2015-11-03 2025-03-21 Apriligen Inc Compuestos para el tratamiento de trastornos hipoproliferativos
AU2017366901B2 (en) 2016-11-30 2022-09-29 Bantam Pharmaceutical, Llc Substituted pyrazole compounds and methods of using them for treatment of hyperproliferative diseases
MX2019006296A (es) 2016-11-30 2019-11-12 Bantam Pharmaceutical Llc Métodos de uso de compuestos de pirazol y pirazol sustituido y para el tratamiento de enfermedades hiperproliferativas.
US11578067B2 (en) 2017-01-30 2023-02-14 Kyoto University Compound, and method for producing regulatory T cells
EP3691642B1 (en) 2017-10-02 2024-03-06 Boehringer Ingelheim International GmbH [1,6]naphthyridine compounds and derivatives as cdk8/cdk19 inhibitors
WO2021126725A1 (en) * 2019-12-17 2021-06-24 Merck Sharp & Dohme Corp. Novel substituted 1,3,8-triazaspiro[4,5]decane-2,4-dione compounds as indoleamine 2,3-dioxygenase (ido) and/or tryptophan 2,3-dioxygenase (tdo) inhibitors
US20240400993A1 (en) 2021-09-27 2024-12-05 Kyoto University Method for producing t cell
CN118591619A (zh) 2021-11-24 2024-09-03 雷格细胞股份有限公司 人诱导性调节性t细胞及其制作方法
US20250352578A1 (en) 2021-11-24 2025-11-20 Regcell Co., Ltd. Pharmaceutical composition for treating or preventing t cell-related disorders
US20250230411A1 (en) 2022-03-23 2025-07-17 Kyoto University Method for producing regulatory t cells
JPWO2024071010A1 (https=) 2022-09-26 2024-04-04
EP4596684A1 (en) 2022-09-26 2025-08-06 Regcell Co., Ltd. Induced regulatory t cells containing chimeric antigen receptor (car)
EP4663195A1 (en) 2023-02-08 2025-12-17 Regcell Co., Ltd. Pharmaceutical composition for treating or preventing pemphigus
WO2024204553A1 (ja) 2023-03-29 2024-10-03 レグセル株式会社 ヒト誘導性制御性t細胞およびその作製方法、およびt細胞関連疾患を治療または予防するための医薬組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0818241D0 (en) * 2008-10-06 2008-11-12 Cancer Res Technology Compounds and their use
US20130296344A1 (en) * 2010-11-12 2013-11-07 Ruprecht-Karls-Universitat Heidelberg Chromene derivatives and their analoga as wnt pathway antagonists
PH12017500997A1 (en) * 2012-04-04 2018-02-19 Samumed Llc Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
EP2770994B1 (en) * 2012-05-04 2019-08-21 Samumed, LLC 1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
ES2698960T3 (es) * 2012-10-08 2019-02-06 Merck Patent Gmbh Compuestos de 2-aminopiridina

Similar Documents

Publication Publication Date Title
JP2017510590A5 (https=)
TWI879728B (zh) Shp2磷酸酶抑制劑及其使用方法
JP2016500694A5 (https=)
EP3630770B1 (en) Pyrazolo[3,4-b]pyrazine derivatives as shp2 phosphatase inhibitors
JP6631616B2 (ja) CDK阻害剤としての2−アミノ−ピリド[2,3−d]ピリミジン−7(8H)−オン誘導体及びその使用
DE60208792T2 (de) Tyrosin-kinase inhibitoren
EP2953940B1 (en) Piperidin-1-yl and azepin-1-yl carboxylates as muscarinic m4 receptor agonists
EP4010335A1 (en) Shp2 inhibitors
BR112019018991A2 (pt) compostos e composições para tratar distúrbios hematológicos
KR20100042287A (ko) 항암요법으로서의 항-유사분열제 및 아우로라 키나제 억제제 조합물
JP2013539777A5 (https=)
AU1091301A (en) Tyrosine kinase inhibitors
JP2019508384A (ja) 5−置換2−(モルホリン−4−イル)−1,7−ナフチリジン
JP2010513495A (ja) 新規なjnk阻害剤
WO2003009852A1 (en) Tyrosine kinase inhibitors
KR20150120383A (ko) 신규 피라졸 유도체
KR20160056896A (ko) Pim 키나아제 억제제로서 유용한 푸로- 및 티에노-피리딘 카복사미드 화합물
AU2013243020A1 (en) Cyclic amides as MetAP-2 inhibitors
KR20230107419A (ko) 암 치료 방법
TW201822764A (zh) Syk抑制劑
EP2651939A1 (en) SUBSTITUTED N-(1H-INDAZOL-4-YL)IMIDAZO[1,2-a]PYRIDINE-3-CARBOXAMIDE COMPOUNDS AS TYPE III RECEPTOR TYROSINE KINASE INHIBITORS
AU2011344001A1 (en) Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors
WO2014151936A9 (en) Octahydropyrrolopyrroles, their preparation and use
WO2013117645A1 (en) Imidazo [4, 5 -c] pyridine derivatives useful for the treatment of degenerative and inflammatory diseases
BR112020022088A2 (pt) moduladores alostéricos de espiropiperidina de receptores nicotínicos de acetilcolina